Cargando…

Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling

SIMPLE SUMMARY: Multiple myeloma cells mainly proliferate in the bone marrow (BM). Mesenchymal stem cells (MSCs) in the BM of MM patients are tumor supportive and exhibit an inflammatory transcription signature and contribute to drug resistance. Due to their rarity in the BM, downstream functional c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Yi, Weijun, Ma, Li, Lecea, Emily, Hazlehurst, Lori A., Adjeroh, Donald A., Hu, Gangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650304/
https://www.ncbi.nlm.nih.gov/pubmed/37958322
http://dx.doi.org/10.3390/cancers15215148
_version_ 1785135750437666816
author Wang, Lei
Yi, Weijun
Ma, Li
Lecea, Emily
Hazlehurst, Lori A.
Adjeroh, Donald A.
Hu, Gangqing
author_facet Wang, Lei
Yi, Weijun
Ma, Li
Lecea, Emily
Hazlehurst, Lori A.
Adjeroh, Donald A.
Hu, Gangqing
author_sort Wang, Lei
collection PubMed
description SIMPLE SUMMARY: Multiple myeloma cells mainly proliferate in the bone marrow (BM). Mesenchymal stem cells (MSCs) in the BM of MM patients are tumor supportive and exhibit an inflammatory transcription signature and contribute to drug resistance. Due to their rarity in the BM, downstream functional characterization of the cells requires in vitro expansion. We conducted a systemic analysis of public expression data and reported the loss of the inflammatory signature during in vitro expansion. However, further analysis on additional publicly available expression data revealed that cytokine stimulations and coculture with immune cells or cancer cells were able to reactivate the transcription signature. Our findings established a crucial foundation for future research into the contribution of the inflammatory status to the tumor-supportive functions of BM MSCs in disease progression and resistance to therapy. ABSTRACT: Bone marrow mesenchymal stem cells (BM MSCs) play a tumor-supportive role in promoting drug resistance and disease relapse in multiple myeloma (MM). Recent studies have discovered a sub-population of MSCs, known as inflammatory MSCs (iMSCs), exclusive to the MM BM microenvironment and implicated in drug resistance. Through a sophisticated analysis of public expression data from unexpanded BM MSCs, we uncovered a positive association between iMSC signature expression and minimal residual disease. While in vitro expansion generally results in the loss of the iMSC signature, our meta-analysis of additional public expression data demonstrated that cytokine stimulation, including IL1-β and TNF-α, as well as immune cells such as neutrophils, macrophages, and MM cells, can reactivate the signature expression of iMSCs to varying extents. These findings underscore the importance and potential utility of cytokine stimulation in mimicking the gene expression signature of early passage of iMSCs for functional characterizations of their tumor-supportive roles in MM.
format Online
Article
Text
id pubmed-10650304
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106503042023-10-26 Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling Wang, Lei Yi, Weijun Ma, Li Lecea, Emily Hazlehurst, Lori A. Adjeroh, Donald A. Hu, Gangqing Cancers (Basel) Article SIMPLE SUMMARY: Multiple myeloma cells mainly proliferate in the bone marrow (BM). Mesenchymal stem cells (MSCs) in the BM of MM patients are tumor supportive and exhibit an inflammatory transcription signature and contribute to drug resistance. Due to their rarity in the BM, downstream functional characterization of the cells requires in vitro expansion. We conducted a systemic analysis of public expression data and reported the loss of the inflammatory signature during in vitro expansion. However, further analysis on additional publicly available expression data revealed that cytokine stimulations and coculture with immune cells or cancer cells were able to reactivate the transcription signature. Our findings established a crucial foundation for future research into the contribution of the inflammatory status to the tumor-supportive functions of BM MSCs in disease progression and resistance to therapy. ABSTRACT: Bone marrow mesenchymal stem cells (BM MSCs) play a tumor-supportive role in promoting drug resistance and disease relapse in multiple myeloma (MM). Recent studies have discovered a sub-population of MSCs, known as inflammatory MSCs (iMSCs), exclusive to the MM BM microenvironment and implicated in drug resistance. Through a sophisticated analysis of public expression data from unexpanded BM MSCs, we uncovered a positive association between iMSC signature expression and minimal residual disease. While in vitro expansion generally results in the loss of the iMSC signature, our meta-analysis of additional public expression data demonstrated that cytokine stimulation, including IL1-β and TNF-α, as well as immune cells such as neutrophils, macrophages, and MM cells, can reactivate the signature expression of iMSCs to varying extents. These findings underscore the importance and potential utility of cytokine stimulation in mimicking the gene expression signature of early passage of iMSCs for functional characterizations of their tumor-supportive roles in MM. MDPI 2023-10-26 /pmc/articles/PMC10650304/ /pubmed/37958322 http://dx.doi.org/10.3390/cancers15215148 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Lei
Yi, Weijun
Ma, Li
Lecea, Emily
Hazlehurst, Lori A.
Adjeroh, Donald A.
Hu, Gangqing
Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
title Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
title_full Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
title_fullStr Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
title_full_unstemmed Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
title_short Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
title_sort inflammatory bone marrow mesenchymal stem cells in multiple myeloma: transcriptional signature and in vitro modeling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650304/
https://www.ncbi.nlm.nih.gov/pubmed/37958322
http://dx.doi.org/10.3390/cancers15215148
work_keys_str_mv AT wanglei inflammatorybonemarrowmesenchymalstemcellsinmultiplemyelomatranscriptionalsignatureandinvitromodeling
AT yiweijun inflammatorybonemarrowmesenchymalstemcellsinmultiplemyelomatranscriptionalsignatureandinvitromodeling
AT mali inflammatorybonemarrowmesenchymalstemcellsinmultiplemyelomatranscriptionalsignatureandinvitromodeling
AT leceaemily inflammatorybonemarrowmesenchymalstemcellsinmultiplemyelomatranscriptionalsignatureandinvitromodeling
AT hazlehurstloria inflammatorybonemarrowmesenchymalstemcellsinmultiplemyelomatranscriptionalsignatureandinvitromodeling
AT adjerohdonalda inflammatorybonemarrowmesenchymalstemcellsinmultiplemyelomatranscriptionalsignatureandinvitromodeling
AT hugangqing inflammatorybonemarrowmesenchymalstemcellsinmultiplemyelomatranscriptionalsignatureandinvitromodeling